Search Results 71-80 of 15926 for GLP-1 agonist

  1. Type 2 diabetes - Symptoms and causes - Mayo Clinic

    Both type 1 and type 2 diabetes can begin during childhood and adulthood. Type 2 is more common in older adults. But the increase in the number of children ...

  2. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long ... - History of type 1 diabetes. - Treatment with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the period

  3. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    * GLP-1 RA including dual peptide agonists and related molecules (e.g., GLP-1/GIP RA), * DPP-4i, * TZDs, * SGLT2is, * SUs, * Meglitinides, * Insulin (basal ...

  4. Dr. Andres Acosta Archives - Mayo Clinic News Network

    , another GLP-1 medication (sold under the brand names Ozempic and Wegovy), and results are expected soon. They are working to expand the test by ...

  5. A Study Of Milk Consumption In Metabolic Syndrome - Mayo Clinic

    GLP-1 agonist use. Patients on medications related to metabolic syndrome where dose adjustments are planned to be made during the study period. Note: Other ...

  6. A Study to Evaluate Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes - Mayo Clinic

    Current use of anti-obesity pharmacotherapy, medications known to affect weight (e.g., corticosteroids) or GLP-1 agonist/analog for T2DM. A positive score ...

  7. A Study of the Effect of Liraglutide on Weight Loss and Stomach Functions in Obesity - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness ... Liraglutide, a long-acting GLP-1 receptor agonist, is approved for treatment ...

  8. Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study - Mayo Clinic

    Taking a GLP-1 agonist < 6 months. Taking prescription or over-the-counter medications for weight loss in the last 3 months before screening, or planning to ...

  9. The International Diabetes Closed Loop Trial DCLP4 - Mayo Clinic

    Clinical diagnosis, based on investigator assessment, of type 1 diabetes for at least one year and using insulin for at least 1 year. ... GLP-1 agonists ...

  10. Publications - Todd A. Kellogg, M.D. - Mayo Clinic

    Are Glucagon-Like Peptide 1 Receptor Agonists and Bariatric Surgery the Answer to Childhood Obesity? Curr Atheroscler Rep. 2025 Nov 8; 27 (1):112 Epub 2025 Nov ...